Assessment of the Attitudes and Changes in Attitudes of Individuals Aged 65 and Over Toward the Vaccine After Being Informed About COVID-19 Vaccines

Yıl 2023, , 735 - 740, 30.09.2023

Erhan Şimşek , Hümeyra Aslaner , Seçkin Özsaydı , Ali Ramazan Benli

https://doi.org/10.16899/jcm.1328246

Öz

Aim: Study aimed to assess the states of getting the vaccine and attitudes of the population at the age of 65 and above who was at the risk group in terms of mortality caused by COVID-19 after being informed about the COVID-19 vaccines.

Method: Data, retrospectively scanned. Study population consisted of individuals aged 65 and above who were authorized to get the vaccine in the city center of Kayseri and who had not gotten the COVID-19 vaccine yet by the 1st of June 2021.

Results: According to the decisions of getting the vaccine after phone calls, 45% of the participants decided to get the vaccine while 42.9% stated that they would not get the vaccine. mRNA vaccine was the most preferred vaccine (35.4%) after the phone calls.

Conclusion: Results of study reveal that the attitude toward COVID-19 vaccine can be affected by many personal and non-personal factors.

Anahtar Kelimeler

COVID-19 vaccines, information, 65 years and above, vaccine attitude

Destekleyen Kurum

-

Proje Numarası

-

Teşekkür

-

COVID-19 Aşıları Konusunda Bilgilendirme Yapılan 65 Yaş ve Üzeri Bireylerin Aşı Tutumları ve Aşı Tutumlarındaki Değişimin Değerlendirilmesi

Öz

Amaç: Çalışma, COVID-19 aşıları hakkında bilgilendirildikten sonra, COVID-19'un neden olduğu ölümler açısından risk grubunda olan 65 yaş ve üzeri nüfusun aşı yaptırma durumlarını ve tutumlarını değerlendirmeyi amaçlamıştır.

Gereç ve Yöntem: Veriler, retrospektif olarak taranmıştır. Çalışma evreni, 1 Haziran 2021 tarihine kadar Kayseri il merkezinde aşı yaptırma izni olan ve henüz COVID-19 aşısı yaptırmamış 65 yaş ve üzeri bireylerden oluşmaktadır.

Bulgular: Telefon görüşmeleri sonrasında aşı yaptırma kararlarına göre katılımcıların %45'i aşı yaptırmaya karar verirken, %42,9'u aşı yaptırmayacağını belirtmiştir. mRNA aşısı telefon görüşmeleri sonrasında en çok tercih edilen aşı olmuştur (%35,4).

Sonuç: Çalışmanın sonuçları, COVID-19 aşısına yönelik tutumun kişisel ve kişisel olmayan birçok faktörden etkilenebileceğini ortaya koymaktadır.

Anahtar Kelimeler

COVID-19 aşıları, bilgi, 65 yaş ve üstü, aşı tutumu

Proje Numarası

-

Kaynakça

• 1. Kabak M, Çil B, Hocanlı I. Relationship between leukocyte, neutrophil, lymphocyte, platelet counts, and neutrophil to lymphocyte ratio and polymerase chain reaction positivity. Int Immunopharmacol. 2021 Apr;93:107390. doi: 10.1016/j.intimp.2021.107390. Epub 2021 Jan 30. Erratum in: Int Immunopharmacol. 2021 Oct;99:107912. PMID: 33529907; PMCID: PMC7846459.
• 2. Yang Y, Peng F, Wang R et al. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun. 2020;109:102434.
• 3. Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med. 2020;382(21):1969-1973.
• 4. Nguyen T, Henningsen KH, Brehaut JC, Hoe E, Wilson K. Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public. Infect Drug Resist. 2011;4:197–207.
• 5. Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to vaccination: A critical review. Social Science & Medicine. 2014;112:1–11.
• 6. Dubé E, MacDonald NE. Vaccine Acceptance: Barriers, Perceived Risks, Benefits, and Irrational Beliefs. In: Bloom BR, Lambert PH, editors. The Vaccine Book. 2nd ed. Cambridge: Academic Press; 2016 p. 507–28.
• 7. Maurer J, Harris KM, Parker A, Lurie N. Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: Evidence from a nationally representative survey of U.S. adults. Vaccine. 2009;27(42):5732–4.
• 8. Schwarzinger M, Flicoteaux R, Cortarenoda S, Obadia Y, Moatti J-P. Low Acceptability of A/H1N1 Pandemic Vaccination in French Adult Population: Did Public Health Policy Fuel Public Dissonance? PLoS One. 2010;5(4):e10199.
• 9. Sypsa V, Livanios T, Psichogiou M et al. Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill.2009;14(49):19437.
• 10. Raude J, Caille-Brillet AL, Setbon M. The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why? PLoS Curr. 2010;2:RRN1188.
• 11. Williams B, Chang A, Landefeld CS, Ahalt C, Conant R, Chen H. Current diagnosis and treatment: geriatrics. 2nd ed. New York:McGraw Hill Professional; 2014.
• 12. Aslaner H, Aslaner HA, Gökçek MB, Benli AR, Yıldız O. The Effect of Chronic Diseases, Age and Gender on Morbidity and Mortality of COVID-19 Infection. Iran J Public Health. 2021;50(4):721-7
• 13. Aslaner H, Özen B, Erten ZK, Gökçek MB. Death and COVID-19 Anxiety in Home-Quarantined Individuals Aged 65 and Over During the Pandemic. Omega (Westport).2022;85(1):246-58
• 14. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42.
• 15. Shacham M, Greenblatt-Kimron L, Hamama-Raz Y et al. Increased COVID-19 Vaccination Hesitancy and Health Awareness amid COVID-19 Vaccinations Programs in Israel. Int J Environ Res Public Health. 2021;18(7):3804.
• 16. Salali GD, Uysal MS. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol Med. 2020;19:1–3.
• 17. Bhagianadh D, Arora K. COVID-19 Vaccine Hesitancy Among Community-Dwelling Older Adults: The Role of Information Sources. J Appl Gerontol. 2022;41(1):4-11.
• 18. Başaran A, Çi̇l B. Vaccine Opposal In People Over 60 Years Of Age In Mardin/Turkey – A Territory With Low Rate Of Vaccination. J Contemp Med. 2022;12(1):81–5.
• 19. Mutlu HH, Coşkun FO, Sargın M. The Incidence and Awareness of Vaccination Among People Aged 65 and over Applied to a Family Medicine Outpatient Clinic. Ankara Med J. 2018;1:1-13
• 20. Yılmaz Hİ, Turğut B, Çıtlak G et al. Türkiye’de İnsanların COVID-19 Aşısına Bakışı. Dicle Med J. 2021 (48)3;583–94.
• 21. Wang J, Jing R, Lai X et al. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines (Basel). 2020;8(3):482.
• 22. Lazarus JV, Ratzan SC, Palayew A et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–8.
• 23. Yildiz Y, Telatar TG, Baykal M, Aykanat B, Yildiz İE. Covid-19 Pandemisi Döneminde Aşı Reddinin değerlendirilmesi. DÜ Sağlık Bil Enst Derg. 2021; 11(2): 200-5.
• 24. Dror AA, Eisenbach N, Taiber S et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775–9.
• 25. Neumann-Böhme S, Varghese NE, Sabat I et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21(7):977–82.
• 26. Latkin CA, Dayton L, Yi G, Konstantopoulos A, Boodram B. Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective. Soc Sci Med. 2021;270:113684.
• 27. Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. 2020;38(42):6500–7.